These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19801661)

  • 21. Proteolytic interactions of factor IXa with human factor VIII and factor VIIIa.
    Lamphear BJ; Fay PJ
    Blood; 1992 Dec; 80(12):3120-6. PubMed ID: 1467518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
    Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
    Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated protein C-catalyzed proteolysis of factor VIIIa alters its interactions within factor Xase.
    Regan LM; O'Brien LM; Beattie TL; Sudhakar K; Walker FJ; Fay PJ
    J Biol Chem; 1996 Feb; 271(8):3982-7. PubMed ID: 8626729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of phosphatidylethanolamine in assembly and function of the factor IXa-factor VIIIa complex on membrane surfaces.
    Falls LA; Furie B; Furie BC
    Biochemistry; 2000 Oct; 39(43):13216-22. PubMed ID: 11052674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.
    Wakabayashi H; Monaghan M; Fay PJ
    J Biol Chem; 2014 May; 289(20):14020-9. PubMed ID: 24692542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
    Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
    J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
    Sheehan JP; Kobbervig CE; Kirkpatrick HM
    Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.
    Monaghan M; Wakabayashi H; Griffiths AE; Fay PJ
    J Thromb Haemost; 2016 May; 14(5):1021-30. PubMed ID: 26878264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface.
    Wakabayashi H; Varfaj F; Deangelis J; Fay PJ
    Blood; 2008 Oct; 112(7):2761-9. PubMed ID: 18650448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase.
    O'Brien LM; Mastri M; Fay PJ
    Blood; 2000 Mar; 95(5):1714-20. PubMed ID: 10688829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of amino-terminal residues of the heavy chain of factor IXa in the binding of its cofactor, factor VIIIa.
    Hamaguchi N; Bajaj SP; Smith KJ; Stafford DW
    Blood; 1994 Sep; 84(6):1837-42. PubMed ID: 8080989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor IXa protects factor VIIIa from activated protein C. Factor IXa inhibits activated protein C-catalyzed cleavage of factor VIIIa at Arg562.
    Regan LM; Lamphear BJ; Huggins CF; Walker FJ; Fay PJ
    J Biol Chem; 1994 Apr; 269(13):9445-52. PubMed ID: 8144529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex.
    Ngo JC; Huang M; Roth DA; Furie BC; Furie B
    Structure; 2008 Apr; 16(4):597-606. PubMed ID: 18400180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced factor VIIIa stability of A2 domain interface variants results from an increased apparent affinity for the A2 subunit. Results from an increased apparent affinity for the A2 subunit.
    Monaghan M; Wakabayashi H; Griffiths A; Wintermute J; Fay PJ
    Thromb Haemost; 2014 Sep; 112(3):495-502. PubMed ID: 24899227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa.
    Varfaj F; Neuberg J; Jenkins PV; Wakabayashi H; Fay PJ
    Biochem J; 2006 Jun; 396(2):355-62. PubMed ID: 16503879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cleavage of factor VIII heavy chain is required for the functional interaction of a2 subunit with factor IXA.
    Fay PJ; Mastri M; Koszelak ME; Wakabayashi H
    J Biol Chem; 2001 Apr; 276(15):12434-9. PubMed ID: 11278520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction.
    Kolkman JA; Christophe OD; Lenting PJ; Mertens K
    J Biol Chem; 1999 Oct; 274(41):29087-93. PubMed ID: 10506162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity.
    Regan LM; Fay PJ
    J Biol Chem; 1995 Apr; 270(15):8546-52. PubMed ID: 7721754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing hydrophobicity or disulfide bridging at the factor VIII A1 and C2 domain interface enhances procofactor stability.
    Wakabayashi H; Griffiths AE; Fay PJ
    J Biol Chem; 2011 Jul; 286(29):25748-55. PubMed ID: 21628455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a plasmin-interactive site within the A2 domain of the factor VIII heavy chain.
    Nogami K; Nishiya K; Saenko EL; Takeyama M; Tanaka I; Yoshioka A; Shima M
    Biochim Biophys Acta; 2008 May; 1784(5):753-63. PubMed ID: 18329389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.